Xinlu Zhang1, Yaping Wang1, Shujun Zhao1,2, Qiaohong Qin1,2, Min Zhang1, Yi Jiang1, Hai Zhu1, Hongyu Li1,2. 1. Gynecologic Oncology, The Third Affiliated Hospital of Zhengzhou University Zhengzhou 450000, Henan, P. R. China. 2. Zhengzhou Key Laboratory of Gynecological Oncology, The Third Affiliated Hospital of Zhengzhou University Zhengzhou 450000, Henan, P. R. China.
Abstract
OBJECTIVE: For investigating Dbx2's expression in endometrial cancer (EC) and its effect on prognosis of patients with EC. METHODS: A comparison was performed in the Cancer Genome Atlas (TCGA) database in terms of the expression profiling of EC and the survival data. To obtain differential expression genes (DEGs), Volcano plot and Venn analysis were adopted. DEGs function was performed by carrying out the GO annotation analysis (GO) and gene set enrichment analysis (GSEA). In clinical EC samples, PCR was applied to the verification of Dbx2's expression. RESULTS: Dbx2 was a downregulated expression in tumor tissues. Dbx2 can have a poor prognosis role in EC by regulating the apoptotic signaling pathway and the immune pathway. Lower expression of Dbx2 was related to lymph node metastasis and FIGO stage. CONCLUSION: Dbx2 is downregulated in endometrial cancer, which serves as a biomarker to predict poor prognosis. AJTR
OBJECTIVE: For investigating Dbx2's expression in endometrial cancer (EC) and its effect on prognosis of patients with EC. METHODS: A comparison was performed in the Cancer Genome Atlas (TCGA) database in terms of the expression profiling of EC and the survival data. To obtain differential expression genes (DEGs), Volcano plot and Venn analysis were adopted. DEGs function was performed by carrying out the GO annotation analysis (GO) and gene set enrichment analysis (GSEA). In clinical EC samples, PCR was applied to the verification of Dbx2's expression. RESULTS:Dbx2 was a downregulated expression in tumor tissues. Dbx2 can have a poor prognosis role in EC by regulating the apoptotic signaling pathway and the immune pathway. Lower expression of Dbx2 was related to lymph node metastasis and FIGO stage. CONCLUSION:Dbx2 is downregulated in endometrial cancer, which serves as a biomarker to predict poor prognosis. AJTR
Authors: H Shoji; T Ito; Y Wakamatsu; N Hayasaka; K Ohsaki; M Oyanagi; R Kominami; H Kondoh; N Takahashi Journal: Mech Dev Date: 1996-05 Impact factor: 1.882
Authors: T Kekeeva; A Tanas; A Kanygina; D Alexeev; A Shikeeva; L Zavalishina; Y Andreeva; G A Frank; D Zaletaev Journal: Cancer Lett Date: 2016-02-16 Impact factor: 8.679
Authors: N Colombo; C Creutzberg; F Amant; T Bosse; A González-Martín; J Ledermann; C Marth; R Nout; D Querleu; M R Mirza; C Sessa Journal: Ann Oncol Date: 2015-12-02 Impact factor: 32.976
Authors: Antonio Palumbo Júnior; Vanessa Paiva Leite de Sousa; Francesco Esposito; Marco De Martino; Floriana Forzati; Fábio Carvalho de Barros Moreira; Tatiana de Almeida Simão; Luiz Eurico Nasciutti; Alfredo Fusco; Luis Felipe Ribeiro Pinto; Cláudia Bessa Pereira Chaves; Nathalia Meireles Da Costa Journal: Genes (Basel) Date: 2019-05-15 Impact factor: 4.096